17:11 EDT Summit Therapeutics (SMMT) files to sell 26.68M shares of common stock for holders
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SMMT:
- Summit Therapeutics’ Phase 3 Study on Ivonescimab: A Potential Game-Changer for NSCLC Treatment
- Summit Therapeutics’ Phase 3 Study on Ivonescimab: A Potential Game-Changer in NSCLC Treatment
- Biotech Alert: Searches spiking for these stocks today
- Buy Rating for Summit Therapeutics Driven by Promising HARMONi-6 Trial Results and Improved Safety Profile
- Summit Therapeutics jumps after CAO buys $500,000 shares